Protalix BioTherapeutics (PLX) Institutional Ownership $1.64 +0.09 (+5.81%) Closing price 09/2/2025 04:00 PM EasternExtended Trading$1.64 0.00 (0.00%) As of 09/2/2025 07:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Protalix BioTherapeutics (NYSE:PLX)CurrentInstitutional OwnershipPercentage16.53%Number ofInstitutional Buyers(last 12 months)33TotalInstitutional Inflows(last 12 months)$8.41MNumber ofInstitutional Sellers(last 12 months)7TotalInstitutional Outflows(last 12 months)$649.38K Get PLX Insider Trade Alerts Want to know when executives and insiders are buying or selling Protalix BioTherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data PLX Institutional Buying and Selling by Quarter Protalix BioTherapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/16/2025 Evergreen Capital Management LLC171,338$254K0.0%N/A0.215% 8/15/2025 Bank of America Corp DE21,892$32K0.0%+364,766.7%0.028% 8/14/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.38,075$56K0.0%N/A0.048% 8/13/2025 Diametric Capital LP143,272$212K0.1%N/A0.180% 8/13/2025 Invesco Ltd.45,141$67K0.0%N/A0.057% 8/13/2025 New York State Common Retirement Fund69,000$102K0.0%N/A0.087% 8/12/2025 XTX Topco Ltd73,675$109K0.0%+76.1%0.093% 8/12/2025 JPMorgan Chase & Co.34,545$51K0.0%+2,065.8%0.043% 8/8/2025 Intech Investment Management LLC36,490$54K0.0%N/A0.046% 8/8/2025 Police & Firemen s Retirement System of New Jersey18,554$27K0.0%N/A0.023% Get the Latest News and Ratings for PLX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Protalix BioTherapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/8/2025 Geode Capital Management LLC826,333$1.22M0.0%N/A1.038% 8/7/2025 Cascade Financial Partners LLC17,000$25K0.0%N/A0.021% 8/7/2025 Connor Clark & Lunn Investment Management Ltd.496,216$734K0.0%+2.8%0.623% 8/5/2025 Harel Insurance Investments & Financial Services Ltd.26,000$40K0.0%N/A0.033% 7/29/2025 Orin Green Financial LLC61,200$91K0.0%+22.4%0.077% 6/27/2025 Goldman Sachs Group Inc.289,461$741K0.0%+482.3%0.364% 5/19/2025 Jane Street Group LLC294,318$753K0.0%+159.0%0.370% 5/16/2025 Goldman Sachs Group Inc.289,461$741K0.0%+482.3%0.364% 5/16/2025 NewEdge Advisors LLC15,080$39K0.0%N/A0.019% 5/15/2025 Cubist Systematic Strategies LLC53,380$137K0.0%+82.1%0.067% 5/15/2025 OMERS ADMINISTRATION Corp179,300$459K0.0%N/A0.225% 5/14/2025 Hsbc Holdings PLC25,535$64K0.0%-36.2%0.032% 5/12/2025 Connor Clark & Lunn Investment Management Ltd.482,875$1.24M0.0%N/A0.607% 5/8/2025 XTX Topco Ltd41,826$107K0.0%N/A0.053% 5/8/2025 GSA Capital Partners LLP209,292$536K0.0%-31.5%0.263% 5/6/2025 Orin Green Financial LLC50,000$128K0.1%-30.6%0.063% 4/30/2025 Stratos Wealth Partners LTD.346,400$887K0.0%+28.3%0.444% 2/17/2025 Squarepoint Ops LLC73,940$139K0.0%+33.4%0.100% 2/17/2025 Point72 Asia Singapore Pte. Ltd.53,507$101K0.0%+13.7%0.073% 2/17/2025 Millennium Management LLC387,921$729K0.0%+3.8%0.527% 2/17/2025 Cubist Systematic Strategies LLC29,307$55K0.0%+24.1%0.040% 2/17/2025 Bank of America Corp DE33,714$63K0.0%-25.1%0.046% 2/14/2025 Jane Street Group LLC113,616$214K0.0%+147.2%0.154% 2/14/2025 Northern Trust Corp731,742$1.38M0.0%+1,299.4%0.994% 2/13/2025 Marshall Wace LLP101,899$192K0.0%N/A0.138% 2/13/2025 Renaissance Technologies LLC1,118,000$2.10M0.0%+17.0%1.518% 2/11/2025 Prudential Financial Inc.36,400$68K0.0%N/A0.049% 2/11/2025 Virtu Financial LLC34,276$64K0.0%-21.0%0.047% 2/4/2025 Y Intercept Hong Kong Ltd18,818$35K0.0%N/A0.026% 1/22/2025 PFG Investments LLC20,730$39K0.0%N/A0.028% New Banking Law #1582 Could Unlock $21 Trillion for Americans (Ad)Do you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. If you do…Click here now because they're preparing for what could be the biggest change to our financial syste11/25/2024Sanctuary Advisors LLC37,100$38K0.0%N/A0.050% 11/20/2024 Virtu Financial LLC43,388$44K0.0%N/A0.059% 11/15/2024 XTX Topco Ltd35,058$36K0.0%N/A0.048% 11/15/2024 Jane Street Group LLC45,952$47K0.0%-84.2%0.062% 11/15/2024 Point72 Asia Singapore Pte. Ltd.47,073$48K0.0%-30.9%0.064% 11/5/2024 GSA Capital Partners LLP435,213$444K0.0%+8.5%0.592% 9/16/2024 Cubist Systematic Strategies LLC32,031$37K0.0%N/A0.044% 9/16/2024 Point72 Asia Singapore Pte. Ltd.68,163$80K0.0%N/A0.093% 8/15/2024 AQR Capital Management LLC57,106$67K0.0%N/A0.078% 8/15/2024 Point72 Asia Singapore Pte. Ltd.68,163$80K0.0%N/A0.093% 8/14/2024 Squarepoint Ops LLC137,764$161K0.0%+673.3%0.188% 8/14/2024 Cubist Systematic Strategies LLC32,031$37K0.0%N/A0.044% 8/9/2024 Renaissance Technologies LLC804,600$941K0.0%-2.4%1.097% 8/8/2024 Ground Swell Capital LLC62,234$73K0.1%N/A0.085% 5/20/2024 Virtu Financial LLC157,516$198K0.0%N/A0.215% 5/7/2024 SG Americas Securities LLC21,467$27K0.0%-38.0%0.029% 5/3/2024 GSA Capital Partners LLP493,571$622K0.0%-9.3%0.673% 2/2/2024 Bailard Inc.68,100$121K0.0%N/A0.095% 1/19/2024 Denali Advisors LLC94,700$169K0.1%-14.1%0.132% 11/15/2023 GSA Capital Partners LLP496,781$825K0.1%N/A0.694% 11/13/2023 Connor Clark & Lunn Investment Management Ltd.167,536$278K0.0%+45.0%0.234% 11/7/2023 Barclays PLC46,511$77K0.0%+251.6%0.065% 10/27/2023 Allspring Global Investments Holdings LLC137,906$229K0.0%N/A0.193% 10/24/2023 Bank of New York Mellon Corp165,680$275K0.0%+12.8%0.231% 10/13/2023 SG Americas Securities LLC30,008$50K0.0%N/A0.042% 9/21/2023 Barclays PLC13,230$26K0.0%+561.5%0.018% 8/11/2023 Natixis132,000$264K0.0%N/A0.202% 8/4/2023 American International Group Inc.27,034$54K0.0%N/A0.041% 7/31/2023 Orin Green Financial LLC60,150$120K0.1%N/A0.092% 7/18/2023 Denali Advisors LLC110,200$220K0.1%N/A0.168% 5/10/2023 Connor Clark & Lunn Investment Management Ltd.158,703$333K0.0%N/A0.243% 5/9/2023 Aptus Capital Advisors LLC16,010$34K0.0%N/A0.024% 2/7/2023 Commonwealth Equity Services LLC50,100$68K0.0%N/A0.101% 7/26/2022 Capital Performance Advisors LLP25,974$28K0.0%N/A0.055% 5/9/2022 Meitav Dash Investments Ltd.244,332$257K0.0%N/A0.527% 4/18/2022 Spire Wealth Management148,800$158K0.0%+18.3%0.321% 1/31/2022 Commonwealth Equity Services LLC40,290$33K0.0%N/A0.088% 1/14/2022 Spire Wealth Management125,800$113K0.0%+598.9%0.276% 11/15/2021 GSA Capital Partners LLP254,871$339K0.0%N/A0.559% 11/12/2021Credit Suisse AG31,974$43K0.0%-51.5%0.070% 8/18/2021 Meitav Dash Investments Ltd.244,332$467K0.0%N/A0.538% 8/17/2021 Walleye Capital LLC346,539$662K0.0%N/A0.764% 8/17/2021 Walleye Trading LLC135,000$258K0.0%N/A0.297% 8/17/2021 Bridgeway Capital Management LLC393,890$752K0.0%+30.2%0.868% 8/16/2021 Morgan Stanley1,861,819$3.56M0.0%+3,723,538.0%4.102% 8/16/2021Credit Suisse AG65,925$126K0.0%+559.3%0.145% 8/13/2021 Renaissance Technologies LLC30,075$57K0.0%-94.1%0.066% 8/12/2021 XTX Topco Ltd17,148$33K0.0%N/A0.038% 8/11/2021 Susquehanna Fundamental Investments LLC66,100$126K0.0%N/A0.146% (Data available from 1/1/2016 forward) PLX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PLX shares? During the previous two years, 42 institutional investors and hedge funds held shares of Protalix BioTherapeutics. The most heavily invested institutionals were Renaissance Technologies LLC ($2.10M), Northern Trust Corp ($1.38M), Geode Capital Management LLC ($1.22M), Stratos Wealth Partners LTD. ($887K), Jane Street Group LLC ($753K), Goldman Sachs Group Inc. ($741K), and Connor Clark & Lunn Investment Management Ltd. ($734K).Learn more on Protalix BioTherapeutics' institutional investors. What percentage of Protalix BioTherapeutics' stock is owned by institutional investors? 16.53% of Protalix BioTherapeutics' stock is owned by institutional investors. Learn more on PLX's institutional investor holdings. Which institutional investors have been buying Protalix BioTherapeutics' stock? Of the 40 institutional investors that purchased Protalix BioTherapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Geode Capital Management LLC ($826.33K), Northern Trust Corp ($679.45K), Connor Clark & Lunn Investment Management Ltd. ($548.21K), GSA Capital Partners LLP ($530.75K), Goldman Sachs Group Inc. ($479.50K), Jane Street Group LLC ($248.37K), and Virtu Financial LLC ($200.90K). How much institutional buying is happening at Protalix BioTherapeutics? Institutional investors have bought a total of 4,363,764 shares in the last 24 months. This purchase volume represents approximately $8.41M in transactions. Which of Protalix BioTherapeutics' major shareholders have been selling company stock? The following institutional investors have sold Protalix BioTherapeutics stock in the last 24 months: Jane Street Group LLC ($244.31K), GSA Capital Partners LLP ($96.46K), Orin Green Financial LLC ($22K), Point72 Asia Singapore Pte. Ltd. ($21.09K), Hsbc Holdings PLC ($14.49K), Bank of America Corp DE ($11.28K), and Virtu Financial LLC ($9.11K). How much institutional selling is happening at Protalix BioTherapeutics? Institutional investors have sold a total of 418,734 shares in the last 24 months. This volume of shares sold represents approximately $649.38K in transactions. Related Companies Alumis Major Shareholders Arcturus Therapeutics Major Shareholders Evolus Major Shareholders Bicycle Therapeutics Major Shareholders Tectonic Therapeutic Major Shareholders Nanobiotix Major Shareholders Cullinan Therapeutics Major Shareholders Prime Medicine Major Shareholders Prothena Major Shareholders Autolus Therapeutics Major Shareholders This page (NYSE:PLX) was last updated on 9/3/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Protalix BioTherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Protalix BioTherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PLX Stock Alerts